CClinicalTrials.gg
CompletedNCT04066218Updated Jun 30, 2022

Sexual Function Screening in Childhood Cancer Survivors

An observational study in Childhood Cancer, Survivorship and Sexual Dysfunction, sponsored by University of Colorado, Denver. Completed at 2 sites in United States. Open to participants aged 15 Years to 24 Years. Per ClinicalTrials.gov, last updated 2022-06-30.

Sponsored by University of Colorado, Denver · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
24
Ages
15 Years to 24 Years
Sex
All
01

Study summary

This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.

Read the detailed description

The proposed research will explore patient-centered approaches to evaluating younger Adolescent/young adult Childhood cancer survivors for sexual dysfunction, including strategies for implementation and usability of thePatient-Reported Outcomes Measurement Information® v2.0 Brief Profile for Sexual Function and Satisfaction Brief, an existing adult screening tool. This study will include interviews with 24 patients age 15-24 who were diagnosed with cancer prior to age 18, and treated with chemotherapy, radiation and/or surgery and are now at least two years off therapy.

02

Conditions studied

  • Childhood Cancer
  • Survivorship
  • Sexual Dysfunction
03

In context

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 24 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

  • Sample size

    • Max number of participants that can be enrolled is 30
    • Max number of participants that can be interviewed is 24
  • Gender Male and Female
  • Age Range 15-24
  • Demographic group English-speaking
  • General health status Pediatric cancer survivors (diagnosed at \<18 years of age and now at least 2 years off therapy)
  • Geographic location Children's Hospital Colorado and University of Colorado Hospital

Inclusion criteria

  1. Ability to read and understand the postcard consent.
  2. Stated willingness to comply with all study procedures and be available for the duration of the study.
  3. Age 15-24 at time of enrollment
  4. History of cancer diagnosis, diagnosed at \<18 years old
  5. Off therapy (chemotherapy, surgery, radiation) for a minimum of 2 years
  6. Sufficient cognitive functioning such that participants are able to complete study measures, as determined by their physician and research personnel.

Exclusion criteria

Exclusion Criteria:

  1. Developmental or intellectual disability, as determined by the patient's physician
  2. Received neither chemotherapy nor radiation therapy
  3. Non-English speaking
  4. Non-English reading
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
24 participants (actual)
Patient registry
No

Groups and cohorts

  • age 15-19

    The investigators plan to complete 24 interviews with 12 in the age 15-19 cohort.The investigators will also ensure that at least 8 people from each sex are included in this study.

    Other: Interviews

  • age 20-24

    The investigators plan to complete 24 interviews with 12 in the age 20-24 cohort. The investigators will also ensure that at least 8 people from each sex are included in this study.

    Other: Interviews

Interventions

  • OtherInterviews

    * Participation will serve as verbal consent. * Qualitative PRA will call participant to schedule either phone or in person interview. If via phone, the study PRA performing the interview, will remind them to find a private space to speak. * REDCap link will be sent for PROMIS SexFS Brief. * PRA will perform semistructured interview and guide Think-Aloud to complete the PROMIS SexFS Brief. * Participants will not submit responses to PROMIS SexFS Brief responses after completing the tool.

06

What researchers measure

Primary outcomes

  1. Describe AYA CCS perspectives on implementation of screening for sexual dysfunction, including preferred modality, setting and timing for evaluating sexual dysfunction.

    Qualitative interviews will be conducted by phone by a trained qualitative research interviewer. Interviews will be in-depth and semistructured, utilizing a combination of broad, open-ended questions and more specific probes. The interview guide was developed with the help of Dr. Michael Fisher, PhD, who has expertise in qualitative research methodology. The interviewer will take detailed field notes. This portion of the interview will last approximately 25-35 minutes and will be digitally recorded and professionally transcribed. After each interview, the interviewer will complete an Interview Summary Form, which will serve as a memoing tool and summarize initial themes or impressions that may be relevant to the research question.

    Time frame: 1 year

Secondary outcomes

  1. Assess AYA CCS perceptions of the PROMIS SexFS Brief, an existing adult clinical screening tool for sexual dysfunction, in a qualitative pilot study.

    Participants will be asked to evaluate the PROMIS SexFS Brief, which will be emailed to them at the time of the interview via a unique/secure REDCap link. Participants will be given a choice of which version of the tool they complete (male or female). Participants will be asked to complete the PROMIS SexFS Brief via REDCap while completing Think-Aloud methodology. Via Think-Aloud, participants will be asked to verbalize their thoughts as they proceed through the task, which asks participants to verbalize their thoughts, without probing or additional explanations, as they undertake a task such as completing a clinical screening questionnaire. In accordance with recommendations for conducting Think-Aloud, participants will participate in a warm-up exercise unrelated to sexual dysfunction prior to completing Think-Aloud.

    Time frame: 1 year

07

Study locations

2 sites
  • Children's Hospital Colorado
    Aurora, Colorado 80045, United States
  • Colorado School of Public Health, University of Colorado Denver
    Aurora, Colorado 80045, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04066218
Lead sponsor
University of Colorado, Denver
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Aug 26, 2019
Start date
Sep 16, 2019
Primary completion
Apr 7, 2020
Completion
Jun 1, 2022
Last update
Jun 30, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion